Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Diagnostic or lab reagents on a backing, prepared diag/lab reagents whether or not on a backing, not of heading 3002 or 3006; certified ref materials
Composite diagnostic or laboratory reagents, n.E.S.
Chemicals-other
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $18.23 to $30.38.. | |
Does NSN 6810-00-281-1859 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Brazil | |
What is the NIIN of NSN 6810-00-281-1859? | |
002811859 or 00-281-1859 | |
Does NSN 6810-00-281-1859 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6810-00-281-1859? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Jan 01, 1963 |
Ld50 lc50 mixture: oral ld50 (rat) is 400 mg/kg
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: may cause irritation and burns of
mucous membranes, nose and throat if inhaled. Absorbtion through
the skin may cause nervous system effects. May cause severe
irritation or burns to skin and eyes on c ontact. Ingestion may
cause svere irritation to gi tract and nervous system effects.
chronic: dermatitis.
explanation of carcinogenicity: no ingredient of a concentration of 0.1%
or greater is listed as a carcinogen or suspected carcinogen.
effects of overexposure: inhalation: wheezing, sneezing, shortness of
breath, labored breathing, pulmonary edema. Eyes: pain, redness,
blurred vision, burning sensation. Skin: burning sensation,
redness, skin damage, als may show same signs as inhalation:
burning sensation of throat and maouth, nausea, vomiting.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: inhalation: remove to fresh air. Get immediate medical help.
maintain breathing, give oxygen or artificial respiration if
needed. Eyes: flush with lots of water for at least 15 minutes. Get
immediate medical help. Skin: remove contaminatedclothes and wash
with lots of water and soap. Ingested: if conscious, give milk or
water. Get immediate medical help.
Hcc: f5
boiling pt: b.P. Text: 223f,106c
melt/freeze pt: m.P/f.P text: 16.0f,-8.9c
vapor pres: 25 mm hg
vapor density: 3.0(air=1)
spec gravity: 0.9
solubility in water: appreciable
appearance and odor: colorles liquid; fishy odor.
percent volatiles by volume: unknon
Stability indicator/materials to avoid: yes
strong mineral acids, acid anhydrides, acid chlorides, aluminum, carbon
dioxide, zinc, strong oxidizing agents.
stability condition to avoid: do not allow contact with incompatibles.
hazardous decomposition products: thermal decomposition products may
include toxic oxides of carbon and nitrogen.
Waste disposal methods: dispose of in accordance with local, state and
federal regulations. Reportable quantity= 1 pound.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: piperidine (sara iii)
cas: 110-89-4
rtecs #: tm3500000
fraction by wt: 100%
other rec limits: none recommended